FYERS
Sharma East India Hospitals & Medical Research94.00
+0.00 (+4.79%)

Sharma East India Hospitals & Medical Research Share Price

94.00+0.00 (+4.79%)
-47.82% past 1 Year

Corporate filings & documents

Announcements

Annual report for the year 2026
1 week ago
Notice of 37th Annual General Meeting to be held on 30th September 2026.
1 week ago
Notice of 37th Annual General Meeting to be held on 30th September 2026.
1 week ago
Outcome of Board Meeting held today i.e. Tuesday September 08 2026
1 week ago
Outcome of Board Meeting held today i.e. Tuesday September 08 2026
1 week ago
Newspaper advertisement for publication of unaudited financial results for the quarter ended June 30 2026.
1 month ago
Newspaper advertisement for publication of unaudited financial results for the quarter ended June 30 2026.
1 month ago
approval of unaudited financial results for the quarter ended 30-06-2026 along with limited review report.
1 month ago
approval of unaudited financial results for the quarter ended 30-06-2026 along with limited review report.
1 month ago
Approval of un-audited Financial Results along with Limited Review Report for the quarter ended on 30th June 2026 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement 2015.
1 month ago
Approval of un-audited Financial Results along with Limited Review Report for the quarter ended on 30th June 2026 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement 2015.
1 month ago
Sharma East India Hospitals & Medical Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve 1. To approve IND-AS compliant Standalone Un-audited Financial Results along with Limited Review Report for the quarter ended on 30th June 2026 pursuant to regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015.2. Any other business with permission of Chair and with the consent of a majority of the Directors present in the Meeting including include at least one Independent Director.
1 month ago
Sharma East India Hospitals & Medical Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve 1. To approve IND-AS compliant Standalone Un-audited Financial Results along with Limited Review Report for the quarter ended on 30th June 2026 pursuant to regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015.2. Any other business with permission of Chair and with the consent of a majority of the Directors present in the Meeting including include at least one Independent Director.
1 month ago
Certificate under Reg 74(5) of SEBI (DP) Regulations 2018 for the quarter ended June 30-06-2026.
2 months ago
Certificate under Reg 74(5) of SEBI (DP) Regulations 2018 for the quarter ended June 30-06-2026.
2 months ago
Intimation of closure of trading window for the quarter ended June 30 2026.
3 months ago
Intimation of closure of trading window for the quarter ended June 30 2026.
3 months ago
The Copy of newspaper advertisement of publication of audited financial results for the quarter and year ended March 31 2026.
3 months ago
The Copy of newspaper advertisement of publication of audited financial results for the quarter and year ended March 31 2026.
3 months ago
as per attachment
3 months ago
Approval of audited financial results for the quarter and year ended 31st March 2026
3 months ago
Sharma East India Hospitals & Medical Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve 1. To consider and approve the Standalone Audited Financial Results along with Auditor Report for the year ended March 31 2026 pursuant to regulation 33 of SEBI (LODR) Regulation 2015.2. Any other business with permission of Chair and with the consent of a majority of the Directors present in the Meeting including include at least one Independent Director.
4 months ago
Sharma East India Hospitals & Medical Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve 1. To consider and approve the Standalone Audited Financial Results along with Auditor Report for the year ended March 31 2026 pursuant to regulation 33 of SEBI (LODR) Regulation 2015.2. Any other business with permission of Chair and with the consent of a majority of the Directors present in the Meeting including include at least one Independent Director.
4 months ago
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Sharma East India Hospitals & Medical Research Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L85110RJ1989PLC005206</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>0</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Ms Bhawana Sharma <br/> Designation: Company Secretary cum compliance officer <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Vimal Kumar Joshi <br/> Designation: Chief Financial Officer <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 29/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months ago
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Sharma East India Hospitals & Medical Research Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L85110RJ1989PLC005206</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>0</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Ms Bhawana Sharma <br/> Designation: Company Secretary cum compliance officer <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Vimal Kumar Joshi <br/> Designation: Chief Financial Officer <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 29/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months ago
compliances certificate under Reg74(5) of SEBI(DP) Regulations 2018 for the quarter ended ended 31-03-2026.
5 months ago
intimation for closure of trading Window
5 months ago
As per attachment.
7 months ago
approval of unaudited financial results for the quarter ended December 31 2025.
7 months ago
approval of unaudited financial results for the quarter ended December 31 2025.
7 months ago
Approval of Standalone un-audited Financial Results for the quarter ended December 31 2025 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement 2015 along with limited review report.
7 months ago
Approval of Standalone un-audited Financial Results for the quarter ended December 31 2025 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement 2015 along with limited review report.
7 months ago
Sharma East India Hospitals & Medical Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 inter alia to consider and approve 1. To approve IND-AS compliant Standalone Un-audited Financial Results along with Limited Review Report for the quarter ended on 31st December 2025 pursuant to Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015.2. Any other business with permission of Chair and with the consent of a majority of the Directors present in the Meeting including include at least one Independent Director
7 months ago
Compliance Certificate under regualtion 74(5) of SEBI (DP) Regulation 2018 for the quarter ended December 2025
8 months ago
Intimation For Closure Of Trading Window For Quarter ended 31st Dec 2025.
8 months ago
As per attachment
10 months ago
Resignation of Independent non-executive Director of the Company.
10 months ago
As per attachment.
10 months ago
As per attachment.
10 months ago
Sharma East India Hospitals & Medical Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve 1. To approve IND-AS compliant Standalone Un-audited Financial Results along with Limited Review Report for the quarter ended on 30th September 2025 pursuant to Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015.2. Any other business with permission of Chair and with the consent of a majority of the Directors present in the Meeting including include at least one Independent Director.
10 months ago
Compliances certificate under regulation 74(5) of SEBI (DP_ Regulations 2018 for the qtr ended 30-09-2025.
11 months ago
Voting results and scrutinizer report for the annual geneal meeting held on 30-09-2025.
11 months ago
Proceeding of 36th Annual Genreal Meeting held on 30th September 2025
11 months ago
Intimation of closer of Trading window
11 months ago
As per attachment.
12 months ago

Annual reports

FY 2023-24
FY 2022-23
FY 2020-21

Concalls & investor presentations

Empty box

No presentations found

Sharma East India Hospitals & Medical Research Ltd Share Price Today

The Sharma East India Hospitals & Medical Research Ltd share price today is ₹94.08. During the trading session, the Sharma East India Hospitals & Medical Research Ltd share price opened at ₹94.07 and recorded an intraday high of ₹94.08 and a low of ₹94.07. Last closing price was ₹96.00. Over the past 52 weeks, the Sharma East India Hospitals & Medical Research Ltd share price has ranged between ₹80.15 and ₹215.85. The current Sharma East India Hospitals & Medical Research Ltd stock price reflects real-time market activity based on executed trades on the exchange.